Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

Podobne knjige/članki

• Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome
  od: Lee, Hyejin, et al.
  Izdano: (2013)
• Sexuality in women with polycystic ovary syndrome: a pilot study
  od: Jucilene Sales da Paixão Silva, et al.
  Izdano: (2010-12-01)
• Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
  od: Steiner, Charles A., et al.
  Izdano: (2007)
• Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
  od: de Medeiros, Sebastião Freitas, et al.
  Izdano: (2019)
• Rosiglitazone Attenuates Insulin-Like Growth Factor 1 Receptor Survival Signaling in PC-3 Cells
  od: Papageorgiou, Efstathia, et al.
  Izdano: (2008)